Type I Interferon Autoantibody Footprints Reveal Neutralizing Mechanisms and Allow Inhibitory Decoy Design

With footprint profiling, scientists delineated two dominant IFN-I faces commonly recognized by neutralizing IFN-I autoantibody–containing plasmas from aged individuals with HIV-1 and from individuals with severe COVID-19.